Xiangyuan Wu
- Molecular Biology
- Oncology top 10%
- Epidemiology top 10%
- Hepatology top 2%
- Immunology top 10%
- Co-authors
- Xing LiQu LinDan‐Yun RuanXiaokun MaZhan‐Hong ChenJie ChenYan‐Fang XingDong‐Hao Wu
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (12 papers)Liver Disease Diagnosis and Treatment (10 papers)Hepatitis B Virus Studies (9 papers)
- Cited by
- HepatologyNeurologyCancer Research
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xiangyuan Wu
77 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 135
- Molecular Biology 440
- Oncology 429
- Epidemiology 314
- Hepatology 296
- Immunology 279
Countries citing papers authored by Xiangyuan Wu
This map shows the geographic impact of Xiangyuan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangyuan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangyuan Wu more than expected).
Fields of papers citing papers by Xiangyuan Wu
This network shows the impact of papers produced by Xiangyuan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangyuan Wu. The network helps show where Xiangyuan Wu may publish in the future.
Co-authorship network of co-authors of Xiangyuan Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Xiangyuan Wu. A scholar is included among the top collaborators of Xiangyuan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangyuan Wu. Xiangyuan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 37 | |
| 6 | 116 | |
| 7 | 36 | |
| 8 | 42 | |
| 9 | 12 | |
| 10 | 18 | |
| 11 | 21 | |
| 12 | 10 | |
| 13 | 5 | |
| 14 | 35 | |
| 15 | 7 | |
| 16 | 9 | |
| 17 | 88 | |
| 18 | 20 | |
| 19 | 44 | |
| 20 | 13 |
About Xiangyuan Wu
Xiangyuan Wu is a scholar working on Hepatology, Cancer Research and Oncology, having authored 86 papers that have together received 1.5k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis B Virus Studies (9 papers). The work is most often cited by research in Hepatology (296 citations), Neurology (146 citations) and Cancer Research (265 citations). Xiangyuan Wu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xing Li, Qu Lin, Dan‐Yun Ruan, Xiaokun Ma, Zhan‐Hong Chen, Jie Chen, Yan‐Fang Xing, Dong‐Hao Wu, Weina Yang and Xiaoqian Peng. Their work appears in journals such as JAMA, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.